NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

What is a significant warning for all patients taking Ivabradine (Corlanor)?

Risk of hypertension
Risk of diabetes
Risk of QT prolongation
Risk of anemia

The correct answer is: Risk of QT prolongation

Ivabradine (Corlanor) is a medication commonly used to treat certain heart conditions. While it has proven to be effective in many cases, it is important for patients to be aware of a significant warning associated with this medication - the risk of QT prolongation. This condition refers to an abnormal heart rhythm that can potentially become life-threatening. It is important for patients taking Ivabradine to monitor their heart rhythm and report any symptoms of QT prolongation, such as dizziness, fainting, or heart palpitations, to their healthcare provider immediately. While hypertension, diabetes, and anemia may also be risks for some patients, they are not listed as significant warnings specifically for those taking Ivabradine. It is important for patients to always read and understand the potential side effects and warnings associated with any medication they are prescribed.